[Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
作者信息
Ercillo L, Mollica G
出版信息
Minerva Med. 1969 Sep 22;60(76):3604-6.
PMID:5823758
Abstract
摘要
相似文献
1
2
[On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
Minerva Med. 1969 Sep 22;60(76):3600-3.
3
[Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies].[N-环己基-N-甲基-(2-氨基-3,5-二溴苄基)氯化铵在口服和注射给药时对急慢性肺部疾病的黏液溶解作用的临床实验研究]
Minerva Med. 1969 Sep 22;60(76):3557-64.
4
5
[Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
Minerva Med. 1969 Sep 19;60(75):3545-8.
6
[Clinical considerations on a recent preparation with bronchial secretolytic action].
Minerva Med. 1969 Sep 22;60(76):3583-93.
7
Clinical experience with a new secretolytic drug.
Minerva Med. 1969 Sep 22;60(76):3607-10.
8
9
[Clinical trial of a new substance with secretolytic action].
Minerva Med. 1969 Sep 19;60(75):3525-44.
10
Zotero 插件